Effect of oral lactosucrose supplementation on human enteric oxalate-degrading bacteria

Acta Urologica Japonica

Volumn 52, Issue 9, 2006, Pages 687-691

  Takei, Kazushiro ^a   Akakura, Koichiro ^a   Ueda, Takeshi ^a   Mikami, Kazuo ^a   Ito, Haruo ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bifidobacterium; Lactosucrose; Oxalate degrading bacteria

Indexed keywords

LACTOSE; OXALIC ACID; SUCROSE;

ADULT; ARTICLE; BIFIDOBACTERIUM; BIFIDOBACTERIUM ADOLESCENTIS; CONTROLLED STUDY; DIETARY INTAKE; ENTEROBACTERIACEAE; FECES ANALYSIS; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; SUPPLEMENTATION; URINARY EXCRETION;

ADMINISTRATION, ORAL; ADULT; BIFIDOBACTERIUM; DIETARY SUPPLEMENTS; FECES; HUMANS; INTESTINES; MALE; OXALATES; TRISACCHARIDES;

EID: 33749466039     PISSN: 00181994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Williams HE and Wandzilak TR: Oxalate synthesis, transport and the hyperoxaluric syndromes. J Urol 141: 742-747, 1989
2. Robertson WG and Hughes H: Importance of mild hyperoxaluria in the pathogenesis of urolithiasis: new evidence from studies in the Alabian Peninsula. Scanning Microsc 7: 391-402, 1993
3. Holmes RP, Goodman HO and Assimos DG: Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 59: 270-276, 2001
4. Allison MJ, Dawson KA, Mayberry WR, et al.: O. formigenes gen. nov., sp. nov.: oxalate degrading anaerobes that inhabit the gastrointestinal tract. Arch Microbiol 141: 1-7, 1985
5. Ito H, Masai M, Miyake M, et al.: New oxalate-degrading bacterium from human feces. Int J Urol 3: 83-84, 1996
6. Hokama S, Honma Y, Toma C, et al.: Oxalate-degrading Enterococcus faecalis. Microbiol Immunol 44: 235-240, 2000
7. Hokama S, Toma C, Iwanaga M, et al.: Oxalate-degrading Providencia rettgeri isolated from human stools. Int J Urol 12: 533-538, 2005
8. Duncan SH, Richardson AJ, Kaul P, et al.: Oxalobactor formigenes and its potential role in human health. Appl Environ Microbiol 68: 3841-3847, 2002
9. Campieri C, Campieri M, Bertuzzi V, et al.: Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int 60: 1097-1105, 2001
10. Sidhu H, Hoppe B, Hesse A, et al.: Absence of Oxalobactor formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria. Lancet 352: 1026-1029, 1998
11. Mikami K, Akakura K, Takei K, et al.: Association of absence of intestinal oxalate degrading bacteria with urinary calcium oxalate stone formation. Int J Urol 10: 293-296, 2003
12. Kwak C, Jeong BC, Lee JH, et al.: Molecular identification of Oxalobactor formigenes with the polymerase chain reaction in fresh or frozen fecal samples. BJU Int 88: 627-632, 2001
13. Sidhu H, Schmidt ME, Cornelius JG, et al.: Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobactor formigenes: possible prevention by gut recolonization or enzyme replacement therapy. J Am Soc Nephrol 10: S334-S340, 1999
14. Kumar R, Mukherjee M, Bhandari M, et al.: Role of Oxalobactor formigenes in calcium oxalate stone disease: a study from North India. Eur Urol 41: 318-322, 2002
15. Urol View 1: 20-26, 2003
16. Koyama H: Purification and characterization of oxalate oxidase from Pseudomonas sp. OX-53. Agric Biol Chem 52: 743-748, 1988
17. Sidhu H, Allison MJ, Chow JM, et al.: Rapid reversal of hyperoxaluria in a rat model after probiotic administration of Oxalobactor formigenes. J Urol 166: 1487-1491, 2001